Paclitaxel-Coated Zilver PTX Drug-Eluting Stent Treatment Does Not Result in Increased Long-Term All-Cause Mortality Compared to Uncoated Devices

PURPOSE: Patient-level data from two large studies of the Zilver PTX drug-eluting stent (DES) with long-term follow-up and concurrent non-drug comparator groups were analyzed to determine whether there was an increased mortality risk due to paclitaxel. METHODS: Data from the Zilver PTX randomized co...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cardiovasc Intervent Radiol
Auteurs principaux: Dake, Michael D., Ansel, Gary M., Bosiers, Marc, Holden, Andrew, Iida, Osamu, Jaff, Michael R., Lottes, Aaron E., O’Leary, Erin E., Saunders, Alan T., Schermerhorn, Marc, Yokoi, Hiroyoshi, Zeller, Thomas
Format: Artigo
Langue:Inglês
Publié: Springer US 2019
Sujets:
Clinical Investigation
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6940321/
https://ncbi.nlm.nih.gov/pubmed/31502026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00270-019-02324-4
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires